Microwave zapper could replace lung surgery for some cancers
NCT ID NCT06869122
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device that uses microwave energy to heat and destroy lung tumors. 18 people with lung cancer who are already scheduled for surgery will receive this ablation first. The goal is to see if the device is safe and can effectively kill the tumor, which might one day allow patients to avoid surgery altogether.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Microwave ablation device (MicroBlate Flex)
What this could lead to
If successful, this technique could offer a less invasive option for treating lung tumors, potentially avoiding the need for surgery in future patients.
What could go wrong
This is a very early, small study (18 people) focused on safety and technical success, not on long-term outcomes. The ablation is done before planned surgery, so it's not yet a standalone treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Europeo di Oncologia (IEO), Via Ripamonti 435
NOT_YET_RECRUITINGMilan, 20141, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Royal Brompton and Harefield NHS Foundation Trust, Royal Brompton Hospital, Sydney Street
RECRUITINGLondon, UK, SW3 6NP, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Contact